Glancy Prongay & Murray LLP Reminds Investors of the Deadline in the Class Action Lawsuit Against MiMedx Group, Inc. (MDXG)

LOS ANGELES--()--Glancy Prongay & Murray LLP (“GPM”) reminds investors of the April 25, 2018 deadline to file a lead plaintiff motion in the class action filed on behalf of investors that purchased MiMedx Group, Inc. (“MiMedx” or the “Company”) (NASDAQ: MDXG) securities between March 7, 2013, and February 19, 2018, inclusive (the “Class Period”).

To obtain information or actively participate in the class action, please visit the MiMedx investigation page on our website at www.glancylaw.com/case/mimedx-group-inc-0.

Investors suffering losses on their MiMedx investments are encouraged to contact Lesley Portnoy of GPM to discuss their legal rights in this class action at 310-201-9150 or by email to shareholders@glancylaw.com.

The complaint filed in this class action alleges that, throughout the Class Period, Defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the Company’s business, operations, and prospects. Specifically, Defendants failed to disclose: (1) MiMedx was engaged in a “channel-stuffing” scheme designed to inappropriately recognize revenue that had not yet been realized; (2) that the Company failed to employ proper compliance measures to ensure appropriate accounting practices; (3) that, as a result, the Company’s internal controls over financial reporting were materially weak; (4) that, as a result, the Company’s financial statements were inaccurate and misleading; and, (5) that, as a result of the foregoing, Defendants’ statements about MiMedx’s business, operations, and prospects, were false and misleading and/or lacked a reasonable basis.

Follow us for updates on Twitter: twitter.com/GPM_LLP.

If you purchased shares of MiMedx during the Class Period you may move the Court no later than April 25, 2018 to ask the Court to appoint you as lead. To be a member of the Class you need not take any action at this time; you may retain counsel of your choice or take no action and remain an absent member of the Class. If you wish to learn more about this action, or if you have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Lesley Portnoy, Esquire, of GPM, 1925 Century Park East, Suite 2100, Los Angeles California 90067 at 310-201-9150, Toll-Free at 888-773-9224, by email to shareholders@glancylaw.com, or visit our website at www.glancylaw.com. If you inquire by email please include your mailing address, telephone number and number of shares purchased.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

Contacts

Glancy Prongay & Murray LLP, Los Angeles
Lesley Portnoy, 310-201-9150 or 888-773-9224
shareholders@glancylaw.com
www.glancylaw.com

Release Summary

Glancy Prongay & Murray LLP Reminds Investors of the Deadline in the Class Action Lawsuit Against MiMedx Group, Inc. (MDXG)

$Cashtags

Contacts

Glancy Prongay & Murray LLP, Los Angeles
Lesley Portnoy, 310-201-9150 or 888-773-9224
shareholders@glancylaw.com
www.glancylaw.com